vs

Side-by-side financial comparison of CABOT CORP (CBT) and DXP ENTERPRISES INC (DXPE). Click either name above to swap in a different company.

CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $527.4M, roughly 1.6× DXP ENTERPRISES INC). CABOT CORP runs the higher net margin — 8.6% vs 4.3%, a 4.3% gap on every dollar of revenue. On growth, DXP ENTERPRISES INC posted the faster year-over-year revenue change (12.0% vs -11.1%). CABOT CORP produced more free cash flow last quarter ($57.0M vs $34.5M). Over the past eight quarters, DXP ENTERPRISES INC's revenue compounded faster (13.1% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

DXP Enterprises Inc. is a leading industrial distribution firm that provides maintenance, repair, operations (MRO) supplies, fluid handling equipment, pump systems and related technical services. It primarily serves customers in manufacturing, energy, mining, construction sectors, with core market coverage across North America.

CBT vs DXPE — Head-to-Head

Bigger by revenue
CBT
CBT
1.6× larger
CBT
$849.0M
$527.4M
DXPE
Growing faster (revenue YoY)
DXPE
DXPE
+23.1% gap
DXPE
12.0%
-11.1%
CBT
Higher net margin
CBT
CBT
4.3% more per $
CBT
8.6%
4.3%
DXPE
More free cash flow
CBT
CBT
$22.5M more FCF
CBT
$57.0M
$34.5M
DXPE
Faster 2-yr revenue CAGR
DXPE
DXPE
Annualised
DXPE
13.1%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBT
CBT
DXPE
DXPE
Revenue
$849.0M
$527.4M
Net Profit
$73.0M
$22.8M
Gross Margin
24.9%
31.6%
Operating Margin
15.2%
8.8%
Net Margin
8.6%
4.3%
Revenue YoY
-11.1%
12.0%
Net Profit YoY
-21.5%
6.9%
EPS (diluted)
$1.37
$1.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
DXPE
DXPE
Q4 25
$849.0M
$527.4M
Q3 25
$899.0M
$513.7M
Q2 25
$923.0M
$498.7M
Q1 25
$936.0M
$476.6M
Q4 24
$955.0M
$470.9M
Q3 24
$1.0B
$472.9M
Q2 24
$1.0B
$445.6M
Q1 24
$1.0B
$412.6M
Net Profit
CBT
CBT
DXPE
DXPE
Q4 25
$73.0M
$22.8M
Q3 25
$43.0M
$21.6M
Q2 25
$101.0M
$23.6M
Q1 25
$94.0M
$20.6M
Q4 24
$93.0M
$21.4M
Q3 24
$137.0M
$21.1M
Q2 24
$109.0M
$16.7M
Q1 24
$84.0M
$11.3M
Gross Margin
CBT
CBT
DXPE
DXPE
Q4 25
24.9%
31.6%
Q3 25
24.5%
31.4%
Q2 25
26.4%
31.6%
Q1 25
25.7%
31.5%
Q4 24
24.6%
31.5%
Q3 24
24.0%
30.9%
Q2 24
25.2%
30.9%
Q1 24
24.1%
30.0%
Operating Margin
CBT
CBT
DXPE
DXPE
Q4 25
15.2%
8.8%
Q3 25
15.2%
8.5%
Q2 25
18.1%
9.2%
Q1 25
17.3%
8.5%
Q4 24
16.2%
8.3%
Q3 24
15.0%
8.4%
Q2 24
16.9%
8.4%
Q1 24
15.3%
7.1%
Net Margin
CBT
CBT
DXPE
DXPE
Q4 25
8.6%
4.3%
Q3 25
4.8%
4.2%
Q2 25
10.9%
4.7%
Q1 25
10.0%
4.3%
Q4 24
9.7%
4.5%
Q3 24
13.7%
4.5%
Q2 24
10.7%
3.7%
Q1 24
8.2%
2.7%
EPS (diluted)
CBT
CBT
DXPE
DXPE
Q4 25
$1.37
$1.38
Q3 25
$0.80
$1.31
Q2 25
$1.86
$1.43
Q1 25
$1.69
$1.25
Q4 24
$1.67
$1.28
Q3 24
$2.41
$1.27
Q2 24
$1.94
$1.00
Q1 24
$1.49
$0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
DXPE
DXPE
Cash + ST InvestmentsLiquidity on hand
$230.0M
$303.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
$498.4M
Total Assets
$3.8B
$1.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
DXPE
DXPE
Q4 25
$230.0M
$303.8M
Q3 25
$258.0M
$123.8M
Q2 25
$239.0M
$112.9M
Q1 25
$213.0M
$114.3M
Q4 24
$183.0M
$148.3M
Q3 24
$223.0M
$35.0M
Q2 24
$197.0M
$49.9M
Q1 24
$206.0M
$139.7M
Total Debt
CBT
CBT
DXPE
DXPE
Q4 25
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
Q3 24
$1.1B
Q2 24
Q1 24
Stockholders' Equity
CBT
CBT
DXPE
DXPE
Q4 25
$1.6B
$498.4M
Q3 25
$1.6B
$488.3M
Q2 25
$1.5B
$468.1M
Q1 25
$1.4B
$444.7M
Q4 24
$1.4B
$422.8M
Q3 24
$1.4B
$402.4M
Q2 24
$1.3B
$384.7M
Q1 24
$1.4B
$375.5M
Total Assets
CBT
CBT
DXPE
DXPE
Q4 25
$3.8B
$1.7B
Q3 25
$3.8B
$1.4B
Q2 25
$3.8B
$1.4B
Q1 25
$3.8B
$1.4B
Q4 24
$3.6B
$1.3B
Q3 24
$3.7B
$1.2B
Q2 24
$3.6B
$1.2B
Q1 24
$3.6B
$1.2B
Debt / Equity
CBT
CBT
DXPE
DXPE
Q4 25
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
Q3 24
0.75×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
DXPE
DXPE
Operating Cash FlowLast quarter
$126.0M
$37.8M
Free Cash FlowOCF − Capex
$57.0M
$34.5M
FCF MarginFCF / Revenue
6.7%
6.5%
Capex IntensityCapex / Revenue
8.1%
0.6%
Cash ConversionOCF / Net Profit
1.73×
1.65×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$54.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
DXPE
DXPE
Q4 25
$126.0M
$37.8M
Q3 25
$219.0M
$34.9M
Q2 25
$249.0M
$18.6M
Q1 25
$73.0M
$3.0M
Q4 24
$124.0M
$32.1M
Q3 24
$204.0M
$28.3M
Q2 24
$207.0M
$14.7M
Q1 24
$176.0M
$27.0M
Free Cash Flow
CBT
CBT
DXPE
DXPE
Q4 25
$57.0M
$34.5M
Q3 25
$155.0M
$28.1M
Q2 25
$188.0M
$8.3M
Q1 25
$1.0M
$-16.9M
Q4 24
$47.0M
$22.7M
Q3 24
$112.0M
$24.4M
Q2 24
$155.0M
$5.9M
Q1 24
$133.0M
$24.1M
FCF Margin
CBT
CBT
DXPE
DXPE
Q4 25
6.7%
6.5%
Q3 25
17.2%
5.5%
Q2 25
20.4%
1.7%
Q1 25
0.1%
-3.6%
Q4 24
4.9%
4.8%
Q3 24
11.2%
5.2%
Q2 24
15.3%
1.3%
Q1 24
13.1%
5.8%
Capex Intensity
CBT
CBT
DXPE
DXPE
Q4 25
8.1%
0.6%
Q3 25
7.1%
1.3%
Q2 25
6.6%
2.1%
Q1 25
7.7%
4.2%
Q4 24
8.1%
2.0%
Q3 24
9.2%
0.8%
Q2 24
5.1%
2.0%
Q1 24
4.2%
0.7%
Cash Conversion
CBT
CBT
DXPE
DXPE
Q4 25
1.73×
1.65×
Q3 25
5.09×
1.61×
Q2 25
2.47×
0.79×
Q1 25
0.78×
0.14×
Q4 24
1.33×
1.50×
Q3 24
1.49×
1.34×
Q2 24
1.90×
0.88×
Q1 24
2.10×
2.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

DXPE
DXPE

Service Centers$356.2M68%
Innovative Pumping Solutions$110.0M21%
Supply Chain Services$61.2M12%

Related Comparisons